Sign in
Taking people in United KingdomNo phase

Predicting Who Benefits From Gastric Bypass Surgery for Type 2 Diabetes

Studies adults with type 2 diabetes and obesity after gastric bypass surgery.

Key facts

Who runs it
Imperial College London
Where
London, United KingdomSee the site
Trial code
Registry title
Who Will Benefit From Bariatric Surgery for Diabetes?
Status
Recruiting
People taking part
210 people, planned
Started
1 Oct 2018
Expected to end
5 Oct 2028
Type of study
Observational, 2 groups
Treatments tested
  • Roux-en-Y gastric bypass (RYGB)
Record updated
19 April 2023

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18-80 planning Roux-en-Y gastric bypass surgery who have type 2 diabetes or prediabetes and obesity. It also takes healthy volunteers as a comparison group.

Age
18-80 years
Sex
Men and women can join.
Disease stage
Surgery group: type 2 diabetes or prediabetes, with obesity (BMI ≥30kg/m2). Healthy group: BMI 19 - 25 kg/m2.
Earlier treatment
Surgery group: planning to have Roux-en-Y gastric bypass (RYGB) and can have surgery on the NHS under the NICE 2014 criteria. Weight must be stable for at least 3 months.

Main reasons for not taking part

  • Type 1 diabetes, secondary diabetes, low fasting C-peptide or no β-cell function
  • Current pregnancy
  • Current smoker
  • Cannot have a DEXA scan, or has cirrhosis, ascites or another condition that changes body fat
  • Cannot understand English

The registry criteria, word for word

Show all 29 criteriaShow less

Who can take part

  • Males and females planning to undergo RYGB
  • 18-80 years
  • Type 2 diabetes mellitus or prediabetes
  • Stable weight for at least 3 months
  • Obese (BMI ≥30kg/m2)
  • Eligible for surgery on the National Health Service (NHS) under The National Institute for Health and Care Excellence (NICE) 2014 criteria
  • Aged 18-80 years
  • Male or female
  • Body mass index 19 - 25 kg/m2
  • Stable weight for at least three months

Who cannot take part

  • Type 1 diabetes
  • Secondary diabetes or absence of β-cell function
  • Unable to undergo DEXA, cirrhosis, ascites, or other condition that may modify body fat composition e.g. underlying malignancy
  • History of any medical, or other condition, or use of any medications, including over-the-counter products, which, in the opinion of the investigators, would either interfere with the study
  • Abnormal glucose tolerance and fasting glucose
  • Current pregnancy
  • Inability to give informed consent
  • Low fasting C-peptide
  • Current smoker
  • Participation in another (interventional) trial within the last 3 months
  • Unable to understand English; Healthy volunteers
  • Without access at home to a telephone, or other factor likely to interfere with ability to participate reliably in the study
  • Pregnancy or breastfeeding
  • Unable to maintain adequate contraception for the duration of the study
  • Donated blood during the preceding 3 months or intention to do so before the end of the study
  • Current smoker
  • Participation in another trial within the last 3 months
  • Unable to understand English

Other criteria

  • Bariatric surgery group

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 80 years old?

Where in United Kingdom

  • Imperial College Healthcare NHS TrustLondon, United KingdomContact: Julia S Kenkre, MB BChirTaking people

About the trial

What the trial wants to find out

A study investigating the influence of fat distribution, genetic susceptibility markers for type 2 diabetes (T2DM) and fat distribution, epigenetic and transcriptomic changes and gut hormone responses to a mixed meal on diabetes remission following bariatric surgery.

The 2 groups in the trial

  • Surgical cohort

    Patients with type 2 diabetes undergoing Roux-en-Y gastric bypass surgery

    Treatment: Roux-en-Y gastric bypass (RYGB)

  • Control

    Healthy volunteers with normal body mass index

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Who Will Benefit From Bariatric Surgery for Diabetes? Using Fat Distribution Measurement, Gut Hormone Profiles and Genetic Data to Predict Diabetes Remission
Plain-language title
Predicting Who Benefits From Gastric Bypass Surgery for Type 2 DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT03842475, who can take part
Publications
Record updated
19 April 2023